Differential effects of angiotensin II receptor blockade on pressure-induced left ventricular hypertrophy and fibrosis in rats
- PMID: 10093056
- DOI: 10.1006/jmcc.1998.0879
Differential effects of angiotensin II receptor blockade on pressure-induced left ventricular hypertrophy and fibrosis in rats
Abstract
The effects of the angiotensin II receptor type 1 (AT1) antagonist losartan on pressure overload-induced left ventricular (LV) hypertrophy were studied in female Sprague-Dawley rats. Starting on the day of surgery, losartan (L, 12 mg/kg/day) was administered as continuous intraperitoneal infusion for 2 weeks by using alzet mini-osmotic-pumps (model 2002). This dose of losartan shifted the in vivo dose-response curve of the angiotensin II-induced elevation of left ventricular systolic pressure (LVSP) to the right. Pressure overload was achieved by placing a band around the aortic arch. This caused an aortic stenosis (AS) with an outer diameter of 1.0 mm. The hemodynamic effects were measured in the intact, anesthetized rats (n = 15). The hearts were excised, and the weights of the left (LV) and right ventricle (RV) were determined. Some of these hearts (n = 7) were perfused with collagenase to obtain isolated cardiac myocytes for the measurement of cell volume. Other hearts (n = 8) were examined for morphological changes. In the animals with AS, LVSP was markedly elevated. Furthermore, LV weight and LV myocyte cell volume were increased in this group, while RV weight and RV myocyte cell volume remained stable in all the groups. L had no significant effect on the AS-induced increase in LVSP and cell size parameters, nor on the weight gain of the LV. Histological analysis revealed that the AS-induced enlargement of the mean myocyte diameter was not affected by L. The interstitial collagen fraction was increased in the AS rats and became normalized by L. These data suggest that the renin-angiotensin system might not be involved in the development of pressure-induced cardiac hypertrophy within the time-frame of these experiments, but that it does play a major role in the genesis of the interstitial fibrosis which is a typical feature of this pathophysiological condition.
Similar articles
-
Effects of angiotensin II receptor blockade on hypoxia-induced right ventricular hypertrophy in rats.J Mol Cell Cardiol. 1997 Nov;29(11):2931-9. doi: 10.1006/jmcc.1997.0528. J Mol Cell Cardiol. 1997. PMID: 9405168
-
Gap junction remodeling in hypertrophied left ventricles of aortic-banded rats: prevention by angiotensin II type 1 receptor blockade.J Mol Cell Cardiol. 2001 Feb;33(2):219-31. doi: 10.1006/jmcc.2000.1293. J Mol Cell Cardiol. 2001. PMID: 11162128
-
[Effects of losartan, ramipril and their combination on left ventricular remodeling and function in spontaneous hypertensive rats].Zhonghua Yi Xue Za Zhi. 2005 Nov 30;85(45):3199-204. Zhonghua Yi Xue Za Zhi. 2005. PMID: 16405840 Chinese.
-
[Role of the cardiac renin-angiotensin system in hypertensive heart disease].Herz. 1995 Oct;20(5):322-9. Herz. 1995. PMID: 7498879 Review. German.
-
[Effects of angiotensin II type 1 and type 2 receptor on apoptosis].Nihon Rinsho. 2002 Oct;60(10):1887-92. Nihon Rinsho. 2002. PMID: 12397679 Review. Japanese.
Cited by
-
Role of the angiotensin II receptor blocker valsartan in heart failure.Exp Clin Cardiol. 2001 Winter;6(4):215-21. Exp Clin Cardiol. 2001. PMID: 20428262 Free PMC article.
-
Role of differential signaling pathways and oxidative stress in diabetic cardiomyopathy.Curr Cardiol Rev. 2010 Nov;6(4):280-90. doi: 10.2174/157340310793566145. Curr Cardiol Rev. 2010. PMID: 22043204 Free PMC article.
-
Epigallocatechin-3 gallate prevents cardiac hypertrophy induced by pressure overload in rats.J Vet Sci. 2007 Jun;8(2):121-9. doi: 10.4142/jvs.2007.8.2.121. J Vet Sci. 2007. PMID: 17519564 Free PMC article.
-
The Extracellular Matrix in Ischemic and Nonischemic Heart Failure.Circ Res. 2019 Jun 21;125(1):117-146. doi: 10.1161/CIRCRESAHA.119.311148. Epub 2019 Jun 20. Circ Res. 2019. PMID: 31219741 Free PMC article. Review.
-
Role of microangiopathy in diabetic cardiomyopathy.Heart Fail Rev. 2014 Jan;19(1):25-33. doi: 10.1007/s10741-013-9378-7. Heart Fail Rev. 2014. PMID: 23456446 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials